血清microRNAs作为生物标志物用于子宫腺肌病分子诊断中的可行性

2018-08-30 09:16:58徐爱云桂涛黄美华朱利万贵平
中国医药导报 2018年14期
关键词:生物标志物

徐爱云 桂涛 黄美华 朱利 万贵平

[摘要] 目的 探讨血清microRNAs作为生物标志物用于子宫腺肌病分子诊断的可行性。 方法 选择2015年3月~2018年3月在江苏省中西医结合医院(以下简称“我院”)经病理学确诊的子宫腺肌病患者78例作为研究组,同时收集我院健康体检中心年龄、性别与子宫腺肌病组基本匹配的78名健康体检者作为对照组。利用高通量测序技术对两组血清中的所有miRNAs进行筛选和验证。 结果 研究组血清中microRNAs的表达水平与对照组差异有统计学意义(P < 0.05)。上调的miRNA个数为316个,下调的个数为24个。进一步筛选验证后发现3个miRNA包括miR-22-3p、miR-103a-3p、miR-182-5p的AUC分别是0.900(95%CI:0.839~0.961)、0.828(95%CI:0.747~0.909)、0.844(95%CI:0.766~0.921)。结论 血清microRNAs有可能成为诊断子宫腺肌病的生物标志物。

[关键词] 血清microRNAs;子宫腺肌病;生物标志物;分子诊断

[中图分类号] R711.4 [文献标识码] A [文章编号] 1673-7210(2018)05(b)-0008-04

The feasibility of serum microRNAs as biomarkers for molecular diagnosis of adenomyosis

XU Aiyun1 GUI Tao2 HUANG Meihua2 ZHU Li2 WAN Guiping2

1.The Third Clinical Medical College, Nanjing University of Chinese Medicine, Jiangsu Province, Nanjing 210023, China; 2.Department of Obstetrics and Gynecology, Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Jiangsu Province, Nanjing 210028, China

[Abstract] Objective To explore the feasibility of using serum microRNAs as biomarkers for the molecular diagnosis of adenomyosis. Methods Seventy-eight patients with adenomyosis confirmed by the pathological diagnosis from March 2015 to March 2018 in Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine (here in after referred to as "our hospital") were selected as the study group. At the same time, 78 healthy subjects in our hospital physical examination center whose age, gender basically matched with the adenomyosis group were collected as the control group. All miRNAs in the serum of both groups were screened and validated using high-throughput sequencing technology. Results The expression level of microRNAs in the serum of the study group was significantly different from that in the control group (P < 0.05). There were 316 up-regulated miRNAs and 24 down-regulated miRNAs. After further screening and verification, 3 miRNAs were found to include miR-22-3p, miR-103a-3p, and miR-182-5p, and AUC were 0.900 (95% CI: 0.839-0.961) and 0.828 (95% CI: 0.747-0.909), 0.844 (95% CI: 0.766-0.921) respectively. Conclusion Serum microRNAs may be biomarkers for the diagnosis of adenomyosis.

[Key words] Serum microRNAs; Adenomyosis; Biomarkers; Molecular diagnosis

子宮腺肌病(adenomyosis,AM)是子宫内膜腺体和间质侵入子宫肌层,形成局部或弥漫性病灶的一种雌激素依赖性疾病[1],好发于35~50岁的育龄女性[2]。子宫腺肌病的临床症状主要表现为经量过多、痛经甚至不孕,部分患者无明显症状[3]。由于超声、MRI、CT等影像学检查方法具有操作快捷等特点,仍是目前诊断子宫腺肌病的主要手段。然而,上述几种影像学诊断方法都各有所缺,经腹彩超检查使用的探头频率较低,经阴道彩超对操作者的技术要求较高,超声造影所使用的造影剂具有一定的副作用,MRI费用昂贵使其很难在临床上推广应用等等[4-7]。此外,子宫腺肌病误诊率较高,常被误诊为子宫肌瘤[8-9]。目前术后的病理学诊断仍是诊断子宫腺肌病的金标准[10],但病理诊断通常在子宫全切术后进行,不适用于临床的常规检查。我们仍需要寻找一种早期、特异性高、敏感性高的新标志物。……

登录APP查看全文

猜你喜欢
生物标志物
脑缺血再灌注损伤后小胶质细胞异常活化的生物标志物研究进展
阿尔兹海默症血清多肽组生物标志物研究
分析化学(2017年7期)2017-07-12 17:28:05
MicroRNAs在胃癌中的研究进展
特发性肺纤维化预后相关生物标志物的研究进展
copeptin在心力衰竭中的临床应用价值
脓毒症急性肾损伤早期预警指标的研究进展
基于UPLC—Q—TOF—MS技术的牛血清白蛋白诱导过敏反应的代谢组学研究
基于UPLC—Q—TOF—MS技术的牛血清白蛋白诱导过敏反应的代谢组学研究
一种基于宏基因组模拟数据的生物标志物筛选方法
海洋环境监测中生物标志物的研究进展